Investigational New Drugs

In vitro activity of liposomal N4octadecyl-1--D-arabinofurano-sylcytosine (NOAC), a new lipophilic derivative of 1--D-arabino-furanocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells
pp. 203-210(8)
Authors: Schwendener R.A.; Friedl K.; Depenbrock H.; Schott H.; Hanauske A.-R.

Tetramethylpiperidine-Substituted Phenazines Inhibit the Proliferation of Intrinsically Multidrug Resistant Carcinoma Cell Lines
pp. 211-217(7)
Authors: van Niekerk E.; O'Sullivan J.F.; Jooné G.K.; van Rensburg C.E.J.

Mechanisms of Action of the Novel Sulfonamide Anticancer Agent E7070 on Cell Cycle Progression in Human Non-Small Cell Lung Cancer Cells
pp. 219-227(9)
Authors: Fukuoka K.; Usuda J.; Iwamoto Y.; Fukumoto H.; Nakamura T.; Yoneda T.; Narita N.; Saijo N.; Nishio K.

Altretamine for the Treatment of Metastatic Renal Cell Carcinoma – A Hoosier Oncology Group Trial
pp. 229-231(3)
Authors: Zon R.T.; McClean J.; Helman D.; Ansari R.; Picus J.; Sandler A.; Williams S.D.; Loehrer Sr. P.J.

N-Methylformamide in Advanced Squamous Cancer of the Uterine Cervix: An Eastern Cooperative Oncology Group Phase II Trial
pp. 233-237(5)
Authors: Rajdev L.; Yu Z-F.; Wadler S.; Weller E.; Kahn S.B.; Tormey D.; Skeel R.; Wiernik P.H.

Phase II Trial of CI-980 in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – A Southwest Oncology Group Study
pp. 239-243(5)
Authors: Whitehead R.P.; Unger J.M.; Flaherty L.E.; Eckardt J.R.; Taylor S.A.; Didolkar M.S.; Samlowski W.; Sondak V.K.

Phase II Study of Bryostatin 1 in Patients with Relapsed Multiple Myeloma
pp. 245-247(3)
Authors: Varterasian M.L.; Pemberton P.A.; Hulburd K.; Rodriguez D.H.; Murgo A.; Al-Katib A.M.

Phase II Studies of Bryostatin-1 in Patients with Advanced Sarcoma and Advanced Head and Neck Cancer
pp. 249-254(6)
Authors: Brockstein B.; Samuels B.; Humerickhouse R.; Arietta R.; Fishkin P.; Wade J.; Sosman J.; Vokes E.E.

A Phase II Trial of Weekly Intravenous Ranpirnase (Onconase®), a Novel Ribonuclease in Patients with Metastatic Kidney Cancer
pp. 255-260(6)
Authors: Vogelzang N.J.; Aklilu M.; Stadler W.M.; Dumas M.C.; Mikulski S.M.

Phase II Trial of GM-CSF in Advanced Prostate Cancer
pp. 261-265(5)
Authors: Dreicer R.; See W.A.; Klein E.A.

Instructions for Authors
pp. 267-271(5)